You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DEB-TACE

Showing 1 - 25 of 587
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCC Trial in Pisa (Microwave ablation + Occlusafe + DEB-TACE, Microwave ablation + Occlusafe, Microwave ablation + DEB-TACE)

Recruiting
  • HCC
  • Microwave ablation + Occlusafe + DEB-TACE
  • +2 more
  • Pisa, Italy
    Azienda Ospedaliero-Universitaria Pisana
Oct 21, 2022

HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

Recruiting
  • HCC
  • DEB-TACE and HAIC
  • DEB-TACE
  • Luohe, Henan, China
  • +15 more
Mar 28, 2023

Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

Recruiting
  • Intermediate Stage of Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Oct 6, 2022

Intrahepatic Cholangiocarcinoma Trial (DEB-TACE combined with Surufatinib and Camrelizumab)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • DEB-TACE combined with Surufatinib and Camrelizumab
  • (no location specified)
Feb 9, 2022

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial (DEB-TACE, PVL/PVE+DEB-TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE
  • PVL/PVE+DEB-TACE
  • (no location specified)
Nov 1, 2021

Hepatocellular Carcinoma Trial in Sohag (Doxorubicin-Eluting Beads)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Doxorubicin-Eluting Beads
  • Sohag, Egypt
    Sohag University Hospital
May 5, 2022

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

Not yet recruiting
  • HCC
  • +3 more
  • (no location specified)
Aug 28, 2021

Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • dTACE-HAIC
  • +3 more
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Feb 22, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Drug-eluting bead transarterial chemoembolization (DEB-TACE),

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Drug-eluting bead transarterial chemoembolization (DEB-TACE)
  • Conventional transarterial chemoembolization (cTACE)
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 8, 2021

Hepatocellular Carcinoma Trial in Nanning (DEB-TACE plus Sorafenib, DEB-TACE plus Lenvatinib, DEB-TACE plus PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE plus Sorafenib
  • +2 more
  • Nanning, Guangxi, China
    Guangxi Medical University Cancer Hospital
Feb 7, 2021

Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +4 more
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jan 10, 2022

Carcinoma, Hepatocellular Trial (Regorafenib in combination with nivolumab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Regorafenib in combination with nivolumab
  • Transarterial Chemoembolization (TACE)
  • (no location specified)
Dec 8, 2021

Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

Completed
Has Results
  • Hepatocellular Carcinoma
  • DEB-TACE
  • Madrid, Spain
    Hospital Ramón y Cajal
Mar 27, 2021

Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization, Apatinib Trial in Chengdu (DEB-TACE combined with apatinib and

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • DEB-TACE combined with apatinib and PD-1 antibody
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Apr 4, 2021

Hepatocellular Carcinoma Trial (Camrelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 12, 2021

Hepatocellular Cancer Trial in Dallas (Oncozene-DEB-TACE)

Active, not recruiting
  • Hepatocellular Cancer
  • Oncozene-DEB-TACE
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 27, 2021

Hepatocellular Carcinoma Trial in Delhi (DEB, SBRT)

Recruiting
  • Hepatocellular Carcinoma
  • Delhi, NCT, India
    Medanta
Nov 19, 2021

HepatoCellular Carcinoma Trial (Trans-arterial chemoembolization (TACE), TACE with Drug Eluting Beads procedure)

Completed
Has Results
  • HepatoCellular Carcinoma
  • Trans-arterial chemoembolization (TACE)
  • TACE with Drug Eluting Beads procedure
  • (no location specified)
Sep 27, 2020

Hepatocellular Carcinoma Trial in Beijing (procedure, device, drug)

Recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE
  • +3 more
  • Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Feb 3, 2021

Hepatocellular Carcinoma, Liver Cancer Trial in Granada (Chemoembolization with preloaded microparticles 100 micron and reflux

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • Chemoembolization with preloaded microparticles 100 micron and reflux control microcatheter
  • Granada, Spain
    Juan Jose Ciampi Dopazo
Nov 26, 2020

Carcinoma, Hepatocellular Trial in Bologna (DEB-TACE, TAE)

Recruiting
  • Carcinoma, Hepatocellular
  • DEB-TACE
  • TAE
  • Bologna, Italy
    IRCCS Azienda Ospedaliero-Universitaria di Bologna
Mar 17, 2021

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 25, 2021

Hepatocellular Carcinoma Trial in Washington (TACE with Surefire)

Unknown status
  • Hepatocellular Carcinoma
  • TACE with Surefire
  • Washington, District of Columbia
    Medstar Georgetown University Hospital
Jan 21, 2020